Akebia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapeutics for kidney disease. It has a nephrology-focused commercial team and a robust development organization. The company has two FDA-approved products and collaborates with medical and biopharmaceutical communities, as well as patient organizations, to improve care for individuals affected by kidney disease. Akebia operates from Cambridge, Massachusetts.
